10-Q: Sonendo Reports Q1 2024 Results, Divests Software Segment and Renegotiates Loan Terms

Sonendo, Inc. announced its first quarter 2024 results, which included the divestiture of its software segment and a renegotiated loan agreement, while also reporting a net loss from continuing operations.

Summary

• Sonendo, Inc. reported a net loss of $6.8 million for the first quarter of 2024, which includes a $5.7 million gain from the sale of its software business.
• Revenue from continuing operations was $7.0 million, a decrease of 19% compared to the same period last year.
• The company's gross margin increased to 28% due to higher average selling prices and lower per-unit costs.
• Operating expenses decreased by 28% year-over-year, primarily due to reduced employee-related costs and marketing spend.
• The company completed the sale of its software segment, TDO Software, Inc., for approximately $16 million.
• Sonendo renegotiated its loan agreement, making a $15 million principal payment and agreeing to revised amortization schedules and revenue covenants.
• As of March 31, 2024, Sonendo had $33.6 million in cash and short-term investments and $23.2 million in outstanding term loan principal.
• The company's common stock was delisted from the NYSE and is now trading on the OTCQX.

Sentiment

Score: 3

Explanation: The document presents a mixed picture with some positive developments like improved gross margin and reduced operating expenses, but these are overshadowed by significant negatives such as revenue decline, net loss, delisting from the NYSE, and substantial doubt about the company's ability to continue as a going concern. The need for additional financing and the company's financial instability contribute to a negative sentiment.

Positives

• Gross margin increased to 28% due to higher average selling prices and lower per-unit costs.
• Operating expenses decreased by 28% year-over-year, primarily due to reduced employee-related costs and marketing spend.
• The company successfully divested its software segment for $16 million, resulting in a $5.7 million gain.
• The company renegotiated its loan agreement, reducing the principal by $15 million and modifying covenants.
• The company is actively working to reduce negative cash flow through operating expense reductions.

Negatives

• Revenue from continuing operations decreased by 19% year-over-year.
• The company reported a net loss of $6.8 million for the quarter.
• The company's common stock was delisted from the NYSE.
• The company has a history of net losses and negative cash flows from operations.
• There is substantial doubt about the company's ability to continue as a going concern.

Risks

• The company's ability to continue as a going concern is dependent on its ability to commercialize products and achieve profitability.
• The company needs additional financing to fund its operations and maintain compliance with loan covenants.
• The delisting from the NYSE may negatively impact the company's stockholders and the trading price and liquidity of its common stock.
• The company's revenue is primarily generated from sales of the GentleWave Console and PIs, making it highly dependent on the success of these offerings.
• The company faces risks related to manufacturing, supply chain, and competition.
• The company's future operating results may be difficult to predict and could fall below expectations.

Future Outlook

The company expects to continue to incur net losses for the next several years and will require additional financing to fund its operations and planned growth. The company plans to reduce negative cash flow through operating expense reductions and is evaluating multiple opportunities, including soliciting external investment or seeking strategic partnerships.

Management Comments

• Management is focused on driving adoption of the GentleWave Procedure among endodontists.
• Management intends to increase awareness of the GentleWave Procedure among dental practitioners and patients.
• Management is undertaking continuous margin improvement programs.
• Management is re-prioritizing the commercial organization to increase product adoption.
• Management is evaluating multiple opportunities, which may include soliciting external investment or seeking strategic partnerships.

Industry Context

The company operates in the medical technology industry, specifically in the dental sector, focusing on root canal therapy. The company's GentleWave System competes with conventional methods of RCT. The company is focused on establishing its technology as the standard of care for RCT.

Comparison to Industry Standards

• The company's revenue decline of 19% year-over-year is concerning, as many medical device companies are experiencing growth.
• The company's gross margin of 28% is relatively low compared to established medical device companies, which often have gross margins above 50%.
• The company's operating expense reduction of 28% is a positive step, but it is likely a result of cost-cutting measures due to financial difficulties.
• The company's divestiture of its software segment is a strategic move to focus on its core business, but it also indicates a need to streamline operations.
• The company's renegotiation of its loan agreement is a necessary step to improve its financial position, but it also highlights the company's financial challenges.
• The company's delisting from the NYSE is a significant setback, as it reduces the company's visibility and access to capital.

Management Changes

Stakeholder Impact

• Shareholders are negatively impacted by the delisting from the NYSE and the company's financial instability.
• Employees may be affected by cost-cutting measures and potential restructuring.
• Customers may be concerned about the company's long-term viability and its ability to support its products.
• Creditors may be concerned about the company's ability to repay its debts.

Next Steps

• The company plans to reduce negative cash flow through operating expense reductions.
• The company is evaluating multiple opportunities, which may include soliciting external investment or seeking strategic partnerships.
• The company will continue to focus on commercializing its products and achieving profitability.

Key Dates

Keywords

GentleWave System, root canal therapy, medical technology, dental, software divestiture, loan renegotiation, financial results, net loss, revenue, gross margin, operating expenses, OTCQX, delisting